. Lecanemab: A Second in Class Therapy for the Management of Early Alzheimer's Disease. Innov Pharm. 2024;15(1) Epub 2024 Mar 18 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.